- $4.71bn
- $6.04bn
- $1.81bn
- 65
- 65
- 95
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 1,623 | 1,480 | 1,395 | 1,489 | 1,562 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 1,269 | 1,387 | 1,428 | 855 | 1,217 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 744 | 1,154 | 1,540 | 631 | 778 |
Provision for Income Taxes | |||||
Net Income After Taxes | 578 | 881 | 1,161 | 469 | 581 |
Net Income Before Extraordinary Items | |||||
Net Income | 578 | 881 | 1,161 | 469 | 581 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 561 | 871 | 1,156 | 460 | 564 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.3 | 2.3 | 3.62 | 1.76 | 2.41 |
Dividends per Share |